Monopar Therapeutics Insider Trades
NASDAQ: MNPRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 1 · $104.92K
- Sales
- 36 · $5.68M
- Shares bought / sold
- 1.50K / 64.27K
- Net activity
- Net selling $5.6 million
Monopar Therapeutics insider activity
Over the last 12 months, Monopar Therapeutics insiders reported 73 transactions on SEC Form 4: 1 open-market purchase and 36 sales. Insiders bought $104,925 and sold $5.7 million worth of stock, for net insider selling of $5.6 million. The largest seller was Robinson Chandler, with $2.6 million in reported sales.
The most recent filing shows Tsuchimoto Kim R (Director) reporting a transaction in 856 shares at $30.00 on Nov 4, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put MNPR's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
MNPR insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Nov 4, 2026 | Tsuchimoto Kim RDirector | Sale | 600 | $43.33K | Form 4 |
| Nov 4, 2026 | Tsuchimoto Kim RDirector | Sale | 996 | $71.06K | Form 4 |
| Nov 4, 2026 | Tsuchimoto Kim RDirector | Sale | 1,295 | $91.62K | Form 4 |
| Nov 4, 2026 | Tsuchimoto Kim RDirector | Option exercise | 2,035 | $28.49K | Form 4 |
| Nov 4, 2026 | Tsuchimoto Kim RDirector | Option exercise | 856 | $25.68K | Form 4 |
| Nov 2, 2026 | Anderson RaymondDirector | Sale | 1,502 | $105.20K | Form 4 |
| Nov 2, 2026 | Anderson RaymondDirector | Sale | 200 | $13.74K | Form 4 |
| Nov 2, 2026 | Anderson RaymondDirector | Sale | 600 | $40.24K | Form 4 |
| Nov 2, 2026 | Anderson RaymondDirector | Sale | 840 | $55.57K | Form 4 |
| Nov 2, 2026 | Anderson RaymondDirector | Option exercise | 1,740 | $52.20K | Form 4 |
| Nov 2, 2026 | Anderson RaymondDirector | Option exercise | 1,402 | $42.06K | Form 4 |
| Nov 2, 2026 | Tsuchimoto Kim RDirector | Sale | 1,199 | $84.05K | Form 4 |
| Nov 2, 2026 | Tsuchimoto Kim RDirector | Option exercise | 1,199 | $35.97K | Form 4 |
| Oct 20, 2026 | Robinson ChandlerChief Executive Officer | Tax withholding | 597 | $55.28K | Form 4 |
| Oct 1, 2026 | STARR CHRISTOPHER MDirector | Sale | 799 | $63.66K | Form 4 |
| Oct 1, 2026 | STARR CHRISTOPHER MDirector | Sale | 2,970 | $234.10K | Form 4 |
| Oct 1, 2026 | STARR CHRISTOPHER MDirector | Sale | 4,631 | $361.63K | Form 4 |
| Oct 1, 2026 | STARR CHRISTOPHER MDirector | Option exercise | 8,400 | $42 | Form 4 |
| Sep 30, 2026 | Robinson ChandlerChief Executive Officer | Tax withholding | 4,344 | $346.09K | Form 4 |
| Sep 30, 2026 | Robinson ChandlerChief Executive Officer | Option exercise | 9,801 | — | Form 4 |
| Sep 30, 2026 | Cittadine AndrewChief Operating Officer | Tax withholding | 1,944 | $154.88K | Form 4 |
| Sep 30, 2026 | Cittadine AndrewChief Operating Officer | Option exercise | 4,384 | — | Form 4 |
| Sep 30, 2026 | Vu Quan AnhChief Financial Officer | Tax withholding | 180 | $14.34K | Form 4 |
| Sep 30, 2026 | Vu Quan AnhChief Financial Officer | Option exercise | 614 | — | Form 4 |
| Sep 24, 2026 | Robinson ChandlerChief Executive Officer | Sale | 600 | $53.87K | Form 4 |
| Sep 24, 2026 | Robinson ChandlerChief Executive Officer | Sale | 8,368 | $744.50K | Form 4 |
| Sep 24, 2026 | Robinson ChandlerChief Executive Officer | Sale | 9,638 | $847.76K | Form 4 |
| Sep 24, 2026 | Robinson ChandlerChief Executive Officer | Sale | 10,450 | $910.72K | Form 4 |
| Sep 24, 2026 | Robinson ChandlerChief Executive Officer | Option exercise | 15,000 | $210.00K | Form 4 |
| Sep 24, 2026 | Robinson ChandlerChief Executive Officer | Option exercise | 14,056 | $421.68K | Form 4 |
| Aug 26, 2026 | RIOUX PATRICEActing Chief Medical Officer | Sale | 1 | $111.26 | Form 4 |
| Aug 26, 2026 | RIOUX PATRICEActing Chief Medical Officer | Option exercise | 1,380 | $6.90 | Form 4 |
| Aug 26, 2026 | Tsuchimoto Kim RDirector | Sale | 590 | $67.17K | Form 4 |
| Aug 26, 2026 | Tsuchimoto Kim RDirector | Sale | 602 | $67.98K | Form 4 |
| Aug 26, 2026 | Tsuchimoto Kim RDirector | Sale | 1,098 | $122.80K | Form 4 |
| Aug 26, 2026 | Tsuchimoto Kim RDirector | Sale | 700 | $77.45K | Form 4 |
| Aug 26, 2026 | Tsuchimoto Kim RDirector | Sale | 615 | $67.38K | Form 4 |
| Aug 26, 2026 | Tsuchimoto Kim RDirector | Sale | 485 | $52.78K | Form 4 |
| Aug 26, 2026 | Tsuchimoto Kim RDirector | Sale | 590 | $67.17K | Form 4 |
| Aug 26, 2026 | Tsuchimoto Kim RDirector | Sale | 602 | $67.98K | Form 4 |
| Aug 26, 2026 | Tsuchimoto Kim RDirector | Sale | 1,098 | $122.80K | Form 4 |
| Aug 26, 2026 | Tsuchimoto Kim RDirector | Sale | 700 | $77.45K | Form 4 |
| Aug 26, 2026 | Tsuchimoto Kim RDirector | Sale | 615 | $67.38K | Form 4 |
| Aug 26, 2026 | Tsuchimoto Kim RDirector | Sale | 485 | $52.78K | Form 4 |
| Aug 26, 2026 | Tsuchimoto Kim RDirector | Option exercise | 2,035 | $28.49K | Form 4 |
| Aug 26, 2026 | Tsuchimoto Kim RDirector | Option exercise | 2,055 | $61.65K | Form 4 |
| Aug 25, 2026 | Anderson RaymondDirector | Sale | 1,802 | $203.72K | Form 4 |
| Aug 25, 2026 | Anderson RaymondDirector | Sale | 646 | $71.11K | Form 4 |
| Aug 25, 2026 | Anderson RaymondDirector | Sale | 694 | $76.37K | Form 4 |
| Aug 25, 2026 | Anderson RaymondDirector | Sale | 1,802 | $203.72K | Form 4 |
| Aug 25, 2026 | Anderson RaymondDirector | Sale | 646 | $71.75K | Form 4 |
| Aug 25, 2026 | Anderson RaymondDirector | Sale | 694 | $76.37K | Form 4 |
| Aug 25, 2026 | Anderson RaymondDirector | Option exercise | 1,740 | $52.20K | Form 4 |
| Aug 25, 2026 | Anderson RaymondDirector | Option exercise | 1,402 | $42.06K | Form 4 |
| Jun 30, 2026 | Cittadine AndrewChief Operating Officer | Tax withholding | 2,309 | $213.79K | Form 4 |
| Jun 30, 2026 | Cittadine AndrewChief Operating Officer | Option exercise | 5,254 | — | Form 4 |
| Jun 30, 2026 | Robinson ChandlerChief Executive Officer | Tax withholding | 4,084 | $378.14K | Form 4 |
| Jun 30, 2026 | Robinson ChandlerChief Executive Officer | Option exercise | 12,873 | — | Form 4 |
| Jun 30, 2026 | Vu Quan AnhChief Financial Officer | Tax withholding | 507 | $46.94K | Form 4 |
| Jun 30, 2026 | Vu Quan AnhChief Financial Officer | Option exercise | 1,228 | — | Form 4 |
| Mar 31, 2026 | Cittadine AndrewChief Operating Officer | Tax withholding | 1,571 | $86.08K | Form 4 |
| Mar 31, 2026 | Cittadine AndrewChief Operating Officer | Option exercise | 3,514 | — | Form 4 |
| Mar 31, 2026 | Robinson ChandlerChief Executive Officer | Tax withholding | 1,972 | $108.05K | Form 4 |
| Mar 31, 2026 | Robinson ChandlerChief Executive Officer | Option exercise | 6,732 | — | Form 4 |
| Dec 31, 2025 | Robinson ChandlerChief Executive Officer | Tax withholding | 2,558 | $167.04K | Form 4 |
| Dec 31, 2025 | Robinson ChandlerChief Executive Officer | Option exercise | 8,724 | — | Form 4 |
| Dec 31, 2025 | Cittadine AndrewChief Operating Officer | Tax withholding | 1,889 | $123.35K | Form 4 |
| Dec 31, 2025 | Cittadine AndrewChief Operating Officer | Option exercise | 4,326 | — | Form 4 |
| Dec 26, 2025 | Vu Quan AnhChief Financial Officer | Buy | 1,500 | $104.92K | Form 4 |
| Dec 18, 2025 | KLAUSNER ARTHUR JDirector | Sale | 461 | $31.39K | Form 4 |
| Dec 18, 2025 | KLAUSNER ARTHUR JDirector | Sale | 4,660 | $312.50K | Form 4 |
| Dec 16, 2025 | KLAUSNER ARTHUR JDirector | other | 7,710 | — | Form 4 |
| Dec 16, 2025 | Hendricks Diane10% Owner | other | 43,499 | — | Form 4 |
| Sep 30, 2025 | Robinson ChandlerChief Executive Officer | Tax withholding | 2,646 | $216.10K | Form 4 |
| Sep 30, 2025 | Robinson ChandlerChief Executive Officer | Option exercise | 8,726 | — | Form 4 |
| Sep 30, 2025 | Cittadine AndrewChief Operating Officer | Tax withholding | 1,896 | $154.85K | Form 4 |
| Sep 30, 2025 | Cittadine AndrewChief Operating Officer | Option exercise | 4,327 | — | Form 4 |
| Sep 24, 2025 | Tactic Pharma LLC & Robinson Chandler & Brown Michael J & O'Halloran Thomas V. & Mazar Andrew Paul10% Owner | Sale | 550,229 | $35.00M | Form 4 |
| Jul 14, 2025 | Robinson ChandlerChief Executive Officer | Sale | 16,800 | $672.02K | Form 4 |
| Jul 14, 2025 | Robinson ChandlerChief Executive Officer | Option exercise | 16,800 | $84 | Form 4 |
| Jul 14, 2025 | STARR CHRISTOPHER MDirector | Sale | 16,800 | $672.02K | Form 4 |
| Jul 14, 2025 | STARR CHRISTOPHER MDirector | Option exercise | 16,800 | $84 | Form 4 |
| Jul 14, 2025 | Tsuchimoto Kim RDirector | Sale | 8,904 | $356.17K | Form 4 |
| Jul 14, 2025 | Tsuchimoto Kim RDirector | Option exercise | 8,904 | $44.52 | Form 4 |
| Jun 30, 2025 | Robinson ChandlerChief Executive Officer | Tax withholding | 5,865 | $209.85K | Form 4 |
| Jun 30, 2025 | Robinson ChandlerChief Executive Officer | Option exercise | 13,344 | — | Form 4 |
| Jan 28, 2025 | Robinson ChandlerChief Executive Officer | other | 62,815 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4